American Healthcare REIT IncAHR
Price$51.26Intrinsic value$34.4133% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $34.41median of 1 methodbased on filings through 30 Jun 2026
Market Price $51.26Price as of 30 Sep 2026
Margin of Safety -32.9%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 3.4% (near-term consensus, capped) · years 2–5: 34.6%/yr (balance of the path).27.7% per year
Years 6–10: glide to demonstrated growth own history 53.1%, capped at 20%
Per-year rates
Yr 631.7%Yr 728.8%Yr 825.8%Yr 922.9%Yr 1020.0%
34.6% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (5y) (limited history)53.1%
Discount rate (cost of equity) 8.7%
Volatility vs market (adjusted beta)0.83

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAmerican Healthcare REIT IncAHRReal Estate
Valuation
P/E75.4×
P/S5.0×
P/B2.9×
EV / Revenue5.3×
EV / EBITDA—
Profitability
Gross margin—
Operating margin20.5%
Net margin5.2%
FCF margin7.2%
Returns
ROE3.3%
ROA2.1%
ROIC2.7%
Growth
Revenue growth (YoY)24.2%
5-yr fwd EPS growth27.7%
Financial strength
Debt / Equity0.24×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield2.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.